Antithetical Impacts of Deleterious LRP1B Mutations in Non-Squamous and Squamous NSCLCs on Predicting Benefits from Immune Checkpoint Inhibitor Alone or with Chemotherapy over Chemotherapy Alone: Retrospective Analyses of the POPLAR/OAK and CHOICE-01 Trials
Science China Life Sciences（2024）
关键词
non-squamous NSCLC,squamous NSCLC,LRP1B deleterious mutations,predictive biomarker,immune checkpoint inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要